These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10694736)

  • 61. Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era.
    Ciancio G; Siquijor AP; Burke GW; Roth D; Cirocco R; Esquenazi V; Byrne GE; Miller J
    Clin Transplant; 1997 Jun; 11(3):243-9. PubMed ID: 9193850
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Simultaneous Hodgkin's disease and Kaposi sarcoma in a renal transplant recipient.
    Yaich S; Zagdane S; Charfeddine K; Hssairi D; Hachicha J
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):306-9. PubMed ID: 20228518
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kaposi's sarcoma after renal transplantation.
    Gutiérrez-Dalmau A; Campistol JM
    N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16124128
    [No Abstract]   [Full Text] [Related]  

  • 64. [Lymphoproliferative disease and cancer in the transplant patient].
    Herreros J; Flórez S; Echevarría JR; Fernández AL; Pardo Mindán FJ
    Rev Esp Cardiol; 1995; 48 Suppl 7():129-34. PubMed ID: 8775827
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
    Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
    [No Abstract]   [Full Text] [Related]  

  • 66. Missing impact of cyclosporine on osteoporosis in renal transplant recipients.
    Grotz W; Mundinger A; Gugel B; Exner V; Reichelt A; Schollmeyer P
    Transplant Proc; 1994 Oct; 26(5):2652-3. PubMed ID: 7940828
    [No Abstract]   [Full Text] [Related]  

  • 67. Kaposi's sarcoma after renal transplantation.
    Vella JP; Mosher R; Sayegh MH
    N Engl J Med; 1997 Jun; 336(24):1761. PubMed ID: 9182224
    [No Abstract]   [Full Text] [Related]  

  • 68. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
    Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
    Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
    N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Associations between use of cyclosporine-sparing agents and outcome in kidney transplant recipients.
    McDonald SP; Russ GR
    Kidney Int; 2002 Jun; 61(6):2259-65. PubMed ID: 12028468
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kaposi's sarcoma and cold abscess of the graft in a renal transplant recipient.
    Mansy H; Al-Harbi A; Somorin A; El-Shadly M; Jaber K
    Nephrol Dial Transplant; 1998 Mar; 13(3):789-91. PubMed ID: 9550673
    [No Abstract]   [Full Text] [Related]  

  • 72. Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution.
    Qunibi WY; Barri Y; Alfurayh O; Almeshari K; Khan B; Taher S; Sheth K
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1402-5. PubMed ID: 8442155
    [No Abstract]   [Full Text] [Related]  

  • 73. Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience.
    Shiba N; Chan MC; Kwok BW; Valantine HA; Robbins RC; Hunt SA
    J Heart Lung Transplant; 2004 Feb; 23(2):155-64. PubMed ID: 14761762
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A bivariate parametric model for survival and intermediate event times.
    Epstein LD; Muñoz A
    Stat Med; 1996 Jun; 15(11):1171-85. PubMed ID: 8804146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Additive immunosuppressive effect of hydroxycamptothecin and cyclosporine on rejection of heart transplantation in rats.
    Shi B; Cai M; Qian Y; Zhou W; Mo C; Wang Y
    Transplant Proc; 2007 Dec; 39(10):3429-31. PubMed ID: 18089398
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients.
    Pourfarziani V; Taheri S
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):991-4. PubMed ID: 19861858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil.
    Gomes RM; Guerra Júnior AA; Lemos LL; Costa Jde O; Almeida AM; Alvares J; Filho CS; Cherchiglia ML; Andrade EI; Godman B; Acurcio FA
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):991-9. PubMed ID: 27181131
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
    Valantine H
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S187-93. PubMed ID: 15093804
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model.
    Martinez-Palli G; Hirose R; Liu T; Xu F; Dang K; Feiner J; Serkova NJ; Niemann CU
    Nephrol Dial Transplant; 2011 Jun; 26(6):1813-20. PubMed ID: 21068143
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Visceral Kaposi's sarcoma associated with human herpesvirus 8 seroconversion in a heart transplant recipient.
    Collart F; Kerbaul F; Damaj G; Zandotti C; Vey N; Mesana T; Mouly-Bandini A
    Transplant Proc; 2004 Dec; 36(10):3173-4. PubMed ID: 15686722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.